Does biomolecular characterization of stage II/III colorectal cancer have any prognostic value?

@article{Funaioli2006DoesBC,
  title={Does biomolecular characterization of stage II/III colorectal cancer have any prognostic value?},
  author={Chiara Funaioli and Carmine Pinto and Vita Mutri and Francesca Di Fabio and Claudio Ceccarelli and Andrea A Martoni},
  journal={Clinical colorectal cancer},
  year={2006},
  volume={6 1},
  pages={
          38-45
        }
}
As new improvements in the treatment of colorectal cancer have become available, it has become important to understand the benefits of new therapies or the deleterious effects stemming from the increased risk of toxicity. In particular, a more rational approach to adjuvant chemotherapy for patients with stage II/III disease should be defined by understanding which patients have a higher recurrence risk. Many studies have investigated several molecular markers, but none has been definitively… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

CD93 gene polymorphism is associated with disseminated colorectal cancer

VIEW 1 EXCERPT
CITES BACKGROUND

Selected Topics in the Molecular Pathology of Endometrial Carcinoma.

VIEW 1 EXCERPT
CITES RESULTS

Adjuvant therapy for stage II colon cancer: prognostic and predictive markers.